{"id":196887,"date":"2024-10-01T21:26:01","date_gmt":"2024-10-02T02:26:01","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2024\/10\/arpa-h-fast-tracks-development-of-new-cancer-implant-tech"},"modified":"2024-10-01T21:26:01","modified_gmt":"2024-10-02T02:26:01","slug":"arpa-h-fast-tracks-development-of-new-cancer-implant-tech","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2024\/10\/arpa-h-fast-tracks-development-of-new-cancer-implant-tech","title":{"rendered":"ARPA-H fast tracks development of new cancer implant tech"},"content":{"rendered":"<p><\/p>\n<p><iframe style=\"display: block; margin: 0 auto; width: 100%; aspect-ratio: 4\/3; object-fit: contain;\" src=\"https:\/\/www.youtube.com\/embed\/FruCjsGvCsg?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope;\n   picture-in-picture\" allowfullscreen><\/iframe><\/p>\n<p>The Advanced Research Projects Agency for Health (<a href=\"https:\/\/arpa-h.gov\/\">ARPA-H<\/a>) has awarded $45 million to rapidly develop sense-and-respond implant technology that could slash U.S. cancer-related deaths by more than 50%.<\/p>\n<p>Announced today, the award to a multi-institutional team of researchers, including Carnegie Mellon University, will fast-track development and testing of a new approach to cancer treatment that aims to dramatically improve immunotherapy outcomes for patients with ovarian, pancreatic, and other difficult-to-treat cancers.<\/p>\n<p><img decoding=\"async\" class=\"aligncenter\" alt=\"schematic of the implant technology\" src=\"https:\/\/lifeboat.com\/blog.images\/arpa-h-fast-tracks-development-of-new-cancer-implant-tech5.jpg\"\/><br \/>\n<strong>Source: <\/strong><em>Brandon Martin\/Rice University. <\/em><em>The \u201chybrid advanced molecular manufacturing regulator,\u201d or HAMMR, a \u201cclosed-loop,\u201d drug-producing implant smaller than an adult\u2019s finger is being developed to treat ovarian, pancreatic, and other difficult-to-treat cancers. The implant, which is small enough to be implanted with minimally-invasive surgery, will be able to continuously monitor a patient\u2019s cancer and adjust their immunotherapy dose in real time.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Advanced Research Projects Agency for Health (ARPA-H) has awarded $45 million to rapidly develop sense-and-respond implant technology that could slash U.S. cancer-related deaths by more than 50%. Announced today, the award to a multi-institutional team of researchers, including Carnegie Mellon University, will fast-track development and testing of a new approach to cancer treatment that [\u2026]<\/p>\n","protected":false},"author":534,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1495],"tags":[],"class_list":["post-196887","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-health"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/196887","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/534"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=196887"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/196887\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=196887"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=196887"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=196887"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}